Plaintiffs conduct entitles it to damages and all other remedies at law.
Plaintiffs conduct entitles it to damages and all other remedies at law.
No, the use of an attorney or registered agent is not required for filing a patent application. However, an attorney or registered agent is often a useful resource and the USPTO recommends the use of such for preparing a patent application and conducting the proceedings in the USPTO.
No, the use of an attorney or registered agent is not required for filing a patent application. However, an attorney or registered agent is often a useful resource and the USPTO recommends the use of such for preparing a patent application and conducting the proceedings in the USPTO.
The five primary requirements for patentability are: (1) patentable subject matter; (2) utility; (3) novelty; (4) non-obviousness; and (5) enablement. Like trademarks, patents are territorial, meaning they are enforceable in a specific geographic area.
Many inventors hire a patent attorney to help them navigate the application process, but this is not always necessary or worthwhile. Attorney fees tend to be very expensive, often costing more than the application fees.
Jiang et al have reported the largest series of patients (42 stenoses in 40 patients) treated with stenting for M1 stenosis. The technical success rate of stenting was 97.6% for the lesions and 97.5% for the 40 patients.
Intracranial stenosis, also known as intracranial artery stenosis, is the narrowing of an artery in the brain, which can lead to a stroke. The narrowing is caused by a buildup and hardening of fatty deposits called plaque. This process is known as atherosclerosis.
The prognosis of patients with large artery occlusion disease of the middle cerebral artery is relatively poor, with fatality rates up to 80% 3.
Surgical revascularization has been the mainstay of treatment for medically refractory MCA stenosis, but the appeal of endovascular techniques is increasing. As technology evolves and endovascular efficacy increases, this modality will likely become the treatment of choice for patients who fail medical therapy.
Middle cerebral artery (MCA) stenosis or occlusion is an important type of ischemic cerebrovascular disease, which is the late stage of intracranial atherosclerosis.
A grade of patent without stenosis was given to any vessel displaying no or only minor disturbances in color-flow characteristics and no stenoses of ≥50%. A grade of patent with stenosis was assigned to any vessel displaying moderate or severe disturbances in color-flow characteristics and a stenosis of ≥50%.